Abstract
Gene silencing using antisense RNA or RNA interference (RNAi) is now a popular method used in eukaryotes. However, RNAi mechanism is absent in bacteria, and hence, single-stranded antisense RNAs, DNAs or nucleic acid analogs are used. Gene silencing in bacteria are achieved by either one of the following two approaches: expressing antisense RNAs using expression plasmids or adding synthetic antisense agents into the culture media. Recently, many advances on this method have been reported. In particular, the problem of low silencing efficiency has been solved remarkably, and as a result, this method is being used practically in biotechnology. This review mainly deals with the features and applications of gene silencing as a gene function subtracting method. Also, gene disruption is described as a competing and mutually complementary method.
Keywords: Antisense RNA, Escherichia coli, gene disruption, gene knock-down, gene knock-out, gene silencing, growth essential gene, LNA, locked nucleic acid, paired-termini, peptide nucleic acid, PNA, RNA silencing, ribosome-binding site.
Current Biotechnology
Title:Subtracting Gene Function by Gene Silencing and Disruption in Bacteria
Volume: 1 Issue: 2
Author(s): Nobutaka Nakashima, Shan Goh and Tomohiro Tamura
Affiliation:
Keywords: Antisense RNA, Escherichia coli, gene disruption, gene knock-down, gene knock-out, gene silencing, growth essential gene, LNA, locked nucleic acid, paired-termini, peptide nucleic acid, PNA, RNA silencing, ribosome-binding site.
Abstract: Gene silencing using antisense RNA or RNA interference (RNAi) is now a popular method used in eukaryotes. However, RNAi mechanism is absent in bacteria, and hence, single-stranded antisense RNAs, DNAs or nucleic acid analogs are used. Gene silencing in bacteria are achieved by either one of the following two approaches: expressing antisense RNAs using expression plasmids or adding synthetic antisense agents into the culture media. Recently, many advances on this method have been reported. In particular, the problem of low silencing efficiency has been solved remarkably, and as a result, this method is being used practically in biotechnology. This review mainly deals with the features and applications of gene silencing as a gene function subtracting method. Also, gene disruption is described as a competing and mutually complementary method.
Export Options
About this article
Cite this article as:
Nakashima Nobutaka, Goh Shan and Tamura Tomohiro, Subtracting Gene Function by Gene Silencing and Disruption in Bacteria, Current Biotechnology 2012; 1 (2) . https://dx.doi.org/10.2174/2211550111201020166
DOI https://dx.doi.org/10.2174/2211550111201020166 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Thematic Issue: Challenging Organic Syntheses and Pharmacological Applications of Natural Products and their Derivatives – Part II)
Current Pharmaceutical Design Natural Endoperoxides as Drug Lead Compounds
Current Medicinal Chemistry Natural Naphthoquinones with Great Importance in Medicinal Chemistry
Current Organic Synthesis Computer-Aided Design of a Novel Poly-Epitope Protein in Fusion with an Adjuvant as a Vaccine Candidate Against Leptospirosis
Current Proteomics The β and γ Classes of Carbonic Anhydrase
Current Pharmaceutical Design Association of Genetic Variation with Pneumonia
Current Respiratory Medicine Reviews The Role of IL-15 Signaling in the Induction of Innate Antiviral Responses
Current Signal Transduction Therapy Carbonic Anhydrase Inhibition/Activation: Trip of a Scientist Around the World in the Search of Novel Chemotypes and Drug Targets
Current Pharmaceutical Design Formulation of Rifampicin Loaded PEGylated 5.0G EDA-PAMAM Dendrimers as Effective Long-Duration Release Drug Carriers
Current Drug Therapy False Resistance to Antiparasitic Drugs: Causes from Shelf Availability to Patient Compliance
Anti-Infective Agents in Medicinal Chemistry Evaluation of Substituted Benzaldehydes Against Mycobacterium tuberculosis
Letters in Drug Design & Discovery Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
Current Pharmaceutical Design Antitubercular and Antimicrobial Activity of NH4VO3 Promoted 1,4- Dihydropyridine Incorporated 1,3,4-trisubstituted Pyrazole
Letters in Drug Design & Discovery Synthesis of Cross-linkable 2,5-Diketopiperazine Derivatives
Letters in Organic Chemistry Bioactive Compounds for Effective Management of Drug-Resistant Tuberculosis
Current Bioactive Compounds On the Diversity of Oxidative Bioactivation Reactions on Nitrogen- Containing Xenobiotics
Current Drug Metabolism Lichen Depsidones as Potential Novel Pharmacologically Active Compounds
Mini-Reviews in Organic Chemistry Current Nanotechnological Approaches for an Effective Delivery of Bioactive Drug Molecules to Overcome Drug Resistance Tuberculosis
Current Pharmaceutical Design Desferrioxamine as Immunomodulatory Agent During Microorganism Infection
Current Pharmaceutical Design Dendritic Cells in Pathogenesis of COPD
Current Pharmaceutical Design